NPI: 1235111071 · BENTON, AR 72015 · General Acute Care Hospital · NPI assigned 11/17/2005
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 11/17/2005 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 56,160 | $1.22M |
| 2019 | 60,338 | $1.51M |
| 2020 | 42,843 | $1.17M |
| 2021 | 34,650 | $1.09M |
| 2022 | 40,128 | $1.12M |
| 2023 | 47,149 | $998K |
| 2024 | 37,199 | $705K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| A0425 | Ground mileage, per statute mile | 13,431 | 9,514 | $761K |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 6,401 | 5,155 | $740K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 6,462 | 4,918 | $619K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,566 | 3,092 | $480K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,143 | 3,609 | $387K |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 3,316 | 2,605 | $319K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,668 | 2,957 | $310K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,537 | 3,786 | $291K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 4,275 | 3,050 | $234K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,917 | 1,053 | $232K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 27,578 | 20,948 | $197K |
| 59025 | Fetal non-stress test | 1,334 | 818 | $192K |
| 80048 | Basic metabolic panel (calcium, ionized) | 14,092 | 11,113 | $192K |
| 80053 | Comprehensive metabolic panel | 11,760 | 9,620 | $155K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 2,917 | 2,387 | $150K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,283 | 1,133 | $132K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,557 | 1,342 | $112K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,398 | 1,238 | $96K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,182 | 1,111 | $96K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,120 | 2,643 | $94K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 9,308 | 7,642 | $89K |
| 87634 | 1,250 | 880 | $72K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 778 | 572 | $67K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,602 | 1,449 | $67K |
| 71046 | Radiologic examination, chest; 2 views | 3,459 | 3,076 | $64K |
| 84703 | 6,802 | 5,735 | $63K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,740 | 435 | $61K |
| 83880 | 2,510 | 2,117 | $60K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,561 | 2,153 | $55K |
| 71045 | Radiologic examination, chest; single view | 6,343 | 5,374 | $50K |
| 84484 | 6,069 | 4,200 | $49K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,162 | 3,766 | $47K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 5,820 | 5,040 | $47K |
| 83735 | 8,224 | 6,259 | $46K | |
| 94761 | 2,023 | 1,318 | $45K | |
| 80061 | Lipid panel | 2,229 | 1,988 | $37K |
| 83690 | 5,357 | 4,452 | $37K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 905 | 742 | $36K |
| 81001 | 10,472 | 8,875 | $34K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,672 | 3,939 | $34K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 567 | 447 | $33K |
| 84145 | 2,280 | 1,860 | $33K | |
| 80320 | 1,969 | 1,624 | $27K | |
| 73630 | 1,108 | 975 | $27K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,185 | 1,908 | $25K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,050 | 2,585 | $25K |
| 86901 | 1,187 | 938 | $25K | |
| 86140 | 4,299 | 3,584 | $23K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,297 | 6,067 | $22K |
| 73610 | 1,211 | 1,062 | $22K | |
| 73562 | 694 | 633 | $21K | |
| 87077 | 2,482 | 2,191 | $20K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 456 | 392 | $18K |
| 12001 | 87 | 83 | $18K | |
| 82962 | 3,251 | 1,674 | $18K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 109 | 106 | $17K |
| 73130 | 726 | 653 | $17K | |
| 87088 | 2,095 | 1,864 | $16K | |
| 94760 | 1,155 | 955 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,377 | 1,215 | $16K |
| 80076 | 1,616 | 1,291 | $15K | |
| 73110 | 630 | 566 | $15K | |
| 82565 | 681 | 536 | $14K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 116 | 110 | $14K |
| 83605 | 1,811 | 1,481 | $14K | |
| A0398 | Als routine disposable supplies | 1,587 | 1,441 | $14K |
| 82550 | 2,297 | 1,827 | $13K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 299 | 283 | $13K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 299 | 283 | $13K |
| 85610 | 3,865 | 3,240 | $13K | |
| 87186 | 2,389 | 2,108 | $13K | |
| 81003 | 4,935 | 4,244 | $13K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 285 | 229 | $12K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,817 | 1,514 | $12K |
| 85730 | 2,609 | 2,252 | $12K | |
| 76830 | Ultrasound, transvaginal | 247 | 215 | $12K |
| 85379 | 1,157 | 1,053 | $12K | |
| 82553 | 1,173 | 908 | $11K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 85 | 81 | $11K |
| 73030 | 597 | 519 | $11K | |
| 90715 | 576 | 523 | $11K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 358 | 331 | $10K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | 184 | 136 | $10K |
| 72110 | 314 | 286 | $10K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 293 | 258 | $10K |
| 71020 | 626 | 586 | $9K | |
| 84439 | 883 | 816 | $8K | |
| 87807 | 602 | 581 | $7K | |
| 87400 | 1,243 | 607 | $7K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 157 | 139 | $7K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 108 | 97 | $7K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 62 | 55 | $6K |
| 82805 | 254 | 213 | $6K | |
| 87040 | 646 | 376 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,249 | 1,034 | $5K |
| 86885 | 479 | 370 | $5K | |
| 36415 | Collection of venous blood by venipuncture | 3,014 | 2,275 | $5K |
| 97161 | 118 | 88 | $5K | |
| 86900 | 1,188 | 938 | $4K | |
| A0422 | Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation | 289 | 253 | $4K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 37 | 37 | $4K |
| 81025 | 594 | 528 | $4K | |
| 70486 | 31 | 29 | $4K | |
| 82150 | 569 | 526 | $4K | |
| 82948 | 692 | 416 | $3K | |
| 80050 | General health panel | 74 | 72 | $3K |
| 80164 | 235 | 182 | $3K | |
| 84702 | 330 | 285 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 753 | 503 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 66 | 64 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,818 | 1,479 | $3K |
| 12011 | 13 | 13 | $3K | |
| 73502 | 90 | 87 | $2K | |
| 71010 | 325 | 298 | $2K | |
| 72131 | 29 | 25 | $2K | |
| 74018 | 122 | 112 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 103 | 92 | $2K |
| 73080 | 113 | 106 | $2K | |
| 80329 | 159 | 119 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,491 | 2,115 | $2K |
| 95811 | 12 | 12 | $2K | |
| 82947 | 294 | 263 | $2K | |
| 77066 | Tomosynthesis, mammo | 29 | 26 | $2K |
| J2704 | Injection, propofol, 10 mg | 3,898 | 3,223 | $2K |
| 74022 | 71 | 63 | $2K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,818 | 1,641 | $2K |
| 96376 | 32 | 24 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 113 | 103 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 367 | 276 | $1K |
| 87210 | 252 | 239 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,392 | 1,123 | $1K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 30 | 30 | $1K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 86 | 70 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,676 | 3,086 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 12 | 12 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,637 | 2,834 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | 157 | 126 | $1K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 644 | 565 | $1K |
| 76642 | 76 | 55 | $1K | |
| 81511 | 27 | 14 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,561 | 1,946 | $1K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 90 | 76 | $965.02 |
| 76801 | 25 | 24 | $940.50 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 26 | 26 | $928.80 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 339 | 269 | $843.06 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 575 | 476 | $720.92 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 101 | 87 | $666.66 |
| 74019 | 28 | 28 | $661.57 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 655 | 528 | $648.11 |
| 73090 | 40 | 36 | $634.29 | |
| 88342 | 40 | 39 | $603.80 | |
| J2060 | Injection, lorazepam, 2 mg | 506 | 429 | $594.99 |
| 74230 | 16 | 15 | $582.66 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 22 | 20 | $559.52 |
| 82010 | 93 | 73 | $513.21 | |
| 80055 | 16 | 16 | $474.76 | |
| 82728 | 28 | 28 | $408.45 | |
| 93971 | 12 | 12 | $333.72 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 42 | 40 | $314.00 |
| 83540 | 53 | 48 | $307.04 | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 139 | 129 | $286.05 |
| 80178 | 32 | 26 | $285.08 | |
| 86787 | 15 | 15 | $220.80 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 193 | 146 | $211.32 |
| 73140 | 21 | 13 | $196.32 | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 93 | 25 | $173.86 |
| 87070 | 12 | 12 | $158.80 | |
| 86308 | 25 | 24 | $156.37 | |
| 82607 | 12 | 12 | $150.64 | |
| 83615 | 24 | 24 | $142.74 | |
| 82570 | 20 | 15 | $118.24 | |
| G0378 | Hospital observation service, per hour | 297 | 270 | $106.04 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 17 | 13 | $102.58 |
| 84156 | 21 | 15 | $89.25 | |
| 85651 | 26 | 24 | $81.12 | |
| 84100 | 34 | 27 | $76.41 | |
| 84550 | 14 | 13 | $71.06 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 182 | 137 | $34.57 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 14 | 12 | $32.80 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 95 | 91 | $30.15 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,477 | 1,966 | $23.47 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 46 | 31 | $9.35 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 28 | 27 | $8.76 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 29 | 26 | $7.78 |
| J1171 | Injection, hydromorphone, 0.1 mg | 20 | 15 | $2.70 |
| J3490 | Unclassified drugs | 477 | 345 | $2.45 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 210 | 191 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 17 | 15 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 68 | 66 | $0.00 |
| A0394 | Als specialized service disposable supplies; iv drug therapy | 186 | 91 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 18 | 14 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 26 | 15 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 98 | 82 | $0.00 |